Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)
Clinical trial NCT03173417 · COMPLETED
Trial details
- NCT number
- NCT03173417
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2019-05-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.